valsartan has been researched along with Peripheral Arterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamsson Eryd, S; Bodegård, J; Bozkurt, B; Cleland, JGF; Khordoc, C; Kishi, T; Lund, LH; Savarese, G; Thuresson, M; Vardeny, O; Zhang, R | 1 |
| Chen, Q; Feng, N; Wang, F; Wang, L; Yao, W | 1 |
1 trial(s) available for valsartan and Peripheral Arterial Disease
| Article | Year |
|---|---|
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis Obliterans; C-Reactive Protein; Endovascular Procedures; Enzyme-Linked Immunosorbent Assay; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Interleukin-6; Male; Middle Aged; Peripheral Arterial Disease; Single-Blind Method; Stents; Valsartan | 2020 |
1 other study(ies) available for valsartan and Peripheral Arterial Disease
| Article | Year |
|---|---|
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Glucose; Heart Failure; Hospitalization; Humans; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Peripheral Arterial Disease; Renal Insufficiency, Chronic; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Stroke Volume; United States; Valsartan | 2023 |